Mark Bachleda - Feb 28, 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Commercial Officer
Signature
/s/ Chris Degnan, Attorney-in-Fact for Mark J. Bachleda
Stock symbol
GRTX
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 03:05 PM
Previous filing
Oct 12, 2021
Next filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +75K $0.00 75K Feb 28, 2022 Common Stock 75K $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022.